Results 81 to 90 of about 42,557 (247)

Bilateral Discoid Medial Menisci With a Parameniscal Cyst: A Case Report

Clinical Case Reports, Volume 14, Issue 2, February 2026.
Rare bilateral discoid medial menisci with parameniscal cyst: clinical presentation, imaging, and arthroscopic management ABSTRACT Bilateral discoid medial menisci are an exceptionally rare anatomical variant, and their coexistence with a parameniscal cyst has only been described in isolated cases.
Jean Michel Hovsepian, Johannes Glaser, André Lança Alves, Rafael José Melo Cué, Thilo Schmitt, Stephan Vogt   +5 more
wiley   +1 more source

Event‐free survival and complete response rate as surrogate endpoints for overall survival in high‐risk non–muscle‐invasive bladder cancer: A meta‐analysis of bacillus Calmette‐Guérin—naive or —remote cases

Cancer, Volume 132, Issue 3, 1 February 2026.
Abstract Background Event‐free survival (EFS) and complete response rate (CRR) are recommended as primary endpoints in bladder cancer trials to enable timely assessment of therapeutic benefit. However, their surrogacy relationship with overall survival (OS) in high‐risk non–muscle‐invasive bladder cancer (HR NMIBC) remains unclear.
Rituparna Bhattacharya, Kalé Kponee‐Shovein, Yipeng Gao, Yan Song, Jingyi Liu, Katherine Wei, Ekta Kapadia, Haojie Li, Ashish M. Kamat   +8 more
wiley   +1 more source

Degenerative intraspinal cyst of the cervical spine

Orthopedic Reviews, 2009
We describe two cases of degenerative intraspinal cyst of the cervical spine that caused a gradually progressive myelopathy. One case had a cyst that arose from the facet joint and the other case had a cyst that formed in the ligamentum flavum.
Hidetoshi Nojiri, Soichi Uta, Yoshio Sakuma   +2 more
doaj   +1 more source

Risk Factors for Readmission Following Minimally Invasive Hysterectomy for Benign Indications in the United States—Outpatient and Inpatient Setting

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
Raanan Meyer, Susie Lau, Shannon Salvador, Yosef Nasseri, Moshe Barnajian, Gabriel Levin   +5 more
wiley   +1 more source

Minimal residual disease in solid tumors: Clinical applications and future directions

Cancer, Volume 132, Issue 3, 1 February 2026.
Abstract Minimal residual disease (MRD) refers to the presence of residual cancer cells or tumor‐derived fragments that persist after treatment and remain undetectable by conventional imaging or protein‐based assays. Circulating tumor DNA (ctDNA) has emerged as a dynamic biomarker for MRD detection.
Theresa Abdo, Ahmad Alhalabi, Sacha Yaghi, Mohammad Aloran, You Li, María Herrán, Rami Tfayli, Thomas A. Samuel, Zeina Nahleh   +8 more
wiley   +1 more source

Loss of METTL3 m6A methyltransferase results in short‐term progression and poor treatment outcome of bladder cancer patients

International Journal of Cancer, Volume 158, Issue 3, Page 763-774, 1 February 2026.
What's new? Bladder cancer exhibits a highly heterogeneous molecular landscape and treatment response. The dysregulation of RNA modifications such as m6A has been involved in cancer initiation and progression. This study comprehensively analyzed the expression of the main catalytic component of the m6A methylation machinery in bladder tumors across one
Katerina‐Marina Pilala, Stella Koroneou, Maria‐Alexandra Papadimitriou, Konstantina Panoutsopoulou, Konstantinos Soureas, Georgios‐Christos Giagkos, Panagiotis Levis, Dimitrios Linardoutsos, Konstantinos Stravodimos, Margaritis Avgeris, Andreas Scorilas   +10 more
wiley   +1 more source

Robotic-assisted laparoscopic radical cystectomy: surgical and oncological outcomes

International Brazilian Journal of Urology, 2012
PURPOSE:Our first 91 consecutive cases undergoing a robotic assisted cystectomy were analyzed regarding perioperative outcomes, pathological stages and surgical complications.
Adrian Treiyer, Matthias Saar, Zentia Bütow, Jörn Kamradt, Stefan Siemer, Michael Stöckle   +5 more
doaj   +1 more source

The Value of Preoperative Plasma VEGF Levels in Urothelial Carcinoma of the Bladder Treated with Radical Cystectomy [PDF]

, 2021
Keiichiro Mori, Victor M. Schuettfort, Satoshi Katayama, Ekaterina Laukhtina, Benjamin Pradère, Fahad Quhal, Reza Sari Motlagh, Hadi Mostafaei, Nico C. Grossmann, Paweł Rajwa, Frederik König, Abdulmajeed Aydh, Francesco Soria, Marco Moschini, Pierre I. Karakiewicz, Yair Lotan, Douglas S. Scherr, Martin Haydter, Péter Nyírády, Jeremy Yuen‐Chun Teoh, Shin Egawa, Éva Compérat, Shahrokh F. Shariat   +22 more
openalex   +1 more source

Long‐term outcomes of a cascading salvage strategy for high‐risk non‐muscle‐invasive bladder cancer

BJU International, Volume 137, Issue 2, Page 339-347, February 2026.
Objective To report long‐term oncological outcomes of patients with high‐risk non‐muscle‐invasive bladder cancer (HR‐NMIBC) undergoing bladder‐sparing therapy (BST) after bacillus Calmette–Guérin (BCG) failure. Patients and Methods We retrospectively reviewed patients with HR‐NMIBC treated from 2000 to 2025 with intravesical therapies after BCG failure,
Ian M. McElree, Ryan L. Steinberg, Helen Y. Hougen, Sarah L. Mott, Vignesh T. Packiam, Michael A. O'Donnell   +5 more
wiley   +1 more source

Crucial Contribution of BACH1 to Bladder Cancer Progression via Upregulating Epithelial‐Mesenchymal Transition Pathway

Cancer Science, Volume 117, Issue 2, Page 364-376, February 2026.
BACH1 is associated with poor prognosis in BC patients and plays a critical role in promoting tumor progression and metastasis. Furthermore, we elucidated the mechanism by which BACH1 facilitates tumor progression and metastasis, primarily through activation of the EMT pathway. These findings suggest that BACH1 may serve as a novel prognostic biomarker
Tomoya Hatayama, Kenshiro Takemoto, Kohei Kobatake, Kento Miura, Liyanage P. Perera, Ryoken Yamanaka, Kazuma Yukihiro, Hiroyuki Shikuma, Kyosuke Iwane, Ryo Tasaka, Yuki Kohada, Miki Naito, Shunsuke Miyamoto, Yohei Sekino, Hiroyuki Kitano, Keisuke Goto, Akihiro Goriki, Keisuke Hieda, Osamu Kaminuma, Nobuyuki Hinata   +19 more
wiley   +1 more source